Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Objectives: To identify preventable thromboembolism-related deaths, classify coroner concerns, and explore organisational responses. Study design: Retrospective systematic case series of coroners’ Prevention of Future Deaths reports (PFDs) from 1 July 2013 to 16 November 2022, in England and Wales. Methods: Reports were acquired from the Courts and Tribunals Judiciary website and screened for thromboembolism-related deaths using a reproducible automated computer code. Demographic information, coroners’ concerns, and organisational responses to PFDs were extracted and analysed, including risk factors predisposing to thromboembolism. Results: 112 PFDs (2.7 % of all PFDs) involved a thromboembolism event contributing to death. The average age of death was 59 years, corresponding to an estimated median of 25 years of life lost per death. Just over half of deaths occurred in women (52 %). The most common cause of death was pulmonary embolism (85.7 %). Issues with thromboprophylaxis were common, including incorrect risk assessments (27.7 %). Coroners’ concerns most often related to failures in providing adequate care, including communication failures (15.7 %), issues with following protocols and guidelines (11.8 %), and risk assessments (10.8 %). Only 56 % of organisations who were sent a PFD had a published response. When they did respond, the majority of responses reported initiating changes related to improvements to guidelines and protocols, or education and training. Conclusions: PFDs offer unique insights into the systems and processes leading to preventable thromboembolism-related deaths. Improved awareness and dissemination of PFDs among clinicians and policy-makers, alongside routine monitoring of PFDs, has the potential to improve patient safety and reduce preventable harms from thromboembolic events.

More information Original publication

DOI

10.1016/j.puhe.2025.105928

Type

Journal article

Publication Date

2025-11-01T00:00:00+00:00

Volume

248